Company inventory work in the first quarter
Release time:
2020-08-14
Company Counts First Quarter Work
Proposes Second Quarter Work Requirements
News 4# October 23 , 24 , The Company successively held work analysis meetings for cement sector, pharmaceutical industry and directly affiliated enterprises to summarize the gains and losses of the first quarter work and put forward requirements for the next stage, especially the second quarter work. At the
analysis meeting, the person in charge of each enterprise reported the work situation in the first quarter in the form of PPT , focusing on analyzing the existing problems and proposing solutions and improvement plans. Chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work of each business sector one by one based on the economic and technical data of each enterprise in the first quarter, pointed out the highlights of the work, analyzed the problems and deficiencies, and put forward guidance and work requirements.
Cement Plate: Improve Operational Efficiency and Establish Competitive Advantage
In the first quarter, the overall efficiency of the two cement enterprises increased year-on-year, the overall production indicators improved, and the optimization of management institutions and positions was steadily advancing. Company leaders pointed out that the overall improvement of the national cement industry in 2018 has brought about an improvement in benefits, but because of this, the management and technical advantages of peak cement enterprises have not been fully reflected. With the progress of technology in the cement industry, enterprises continue to increase the intensity of technological transformation, the original advantages continue to reduce, and the gap with the advantages of enterprises is also widening. Therefore, the peak cement must clear ideas, strengthen management innovation and technological innovation, and strive to improve the efficiency of enterprise operation. The
meeting required the two cement enterprises to make equipment management the top priority of their work. The leaders in charge, departments and team leaders should "sink" to the production line, so as to drive the inspection workers and maintenance workers to find and solve problems in time, effectively improve the quality of inspection and equipment maintenance, and ensure the "zero defect" operation of equipment. Further strengthen the management of raw materials, to ensure the stability and reliability of the quality of raw materials, all incoming indicators must be kept in a controllable state, so as to provide guarantee for the stability of product quality; further deepen lean management, strive for excellence in every work detail, and strive to achieve every detail Optimum, so as to improve the overall operation level of the enterprise; with the country and the whole society paying attention to environmental protection, as a traditional manufacturing enterprise, it is necessary to continuously promote the creation of "green factories" and "standardized demonstration factories", and earnestly do a good job in environmental protection and safety management.
According to the specific conditions of the two enterprises, the meeting also requested Daye Peak to further speed up the handling of hazardous waste disposal and related procedures for mining in Xiyeshan Mine, and to do a solid job in environmental improvement and market control. Yunnan Jianfeng should pay close attention to mine renovation, scientific use of lignite and clay mine related work, and strengthen market management to ensure the balance and stability of production and sales.
Peak Pharmaceutical: Grasp the situation, strengthen innovation, and seek a breakthrough
In the recent period, pharmaceutical companies have made significant progress in factory management, technical research, organization optimization, and sales team construction. However, with a series of changes such as the reform of the medical system and the rectification of the pharmaceutical market, the pressure on the production and operation of enterprises has also increased. How to break through the development bottleneck is the most important problem that pharmaceutical companies urgently need to solve. The meeting requested that pharmaceutical companies should fully grasp the current situation, clarify where their current profit growth points are, where future growth points are, how to solve pain points and difficulties, and strive to achieve "curve overtaking" and seek greater development space. Meeting
requires pharmaceutical companies to fully understand the development trend of the industry brought about by the reform of the medical system, strengthen the innovation of marketing mode, management mode and incentive mechanism, increase the introduction of marketing talents, and realize the breakthrough of marketing; new product research and development and consistency evaluation should be carried out in stages on a weekly and monthly basis, set goals, continuously promote and summarize, and ensure the orderly development of the work; the selection and grafting of new development projects and new varieties should have a clear direction, and establish corresponding professional teams and responsibility assessment objectives; the management of new projects should have clear objectives and plans, strengthen management communication and coordination with cooperative enterprises, fully and effectively integrate existing resources, establish competitive advantages, and truly take the road of differentiated development.
Peak Health: Strengthen Scientific and Technological Innovation, Strengthen Quality Management, Accelerate Marketing Breakthrough
Aiming at several major product lines of Peak Health, the meeting called for strengthening the procurement management, quality management and production standards of health care products raw materials, strictly controlling the quality of products, speeding up the construction of health care products marketing team, formulating standardized promotion mode, speeding up marketing expansion and achieving breakthroughs; Clarify the positioning of plant products, focus on the promotion, through technological innovation, patents, the formulation of industry standards and other methods, improve the market threshold, so as to establish a leading advantage in the extract industry; traditional Chinese medicine pieces should strengthen the construction of raw material base, and small package pieces, granules and other attempts; all kinds of products should do a good job in the coordination of production and sales, and strictly control the production cost.
International Trade Company: Strengthen management, improve service quality, and expand enterprise scale
The meeting requires international trade companies to combine the actual situation of the enterprise, strengthen on-site management, eliminate management loopholes, and reduce operating costs; improve management standardization Level, improve service quality; carry out various tasks in a targeted manner, form a business model with advantages and own characteristics, and expand the business scale as soon as possible, establish industry competitive advantage.
Cable Company: Build Confidence, Prevent Risks, Build Brand
In view of the current cable market situation, the meeting asked the cadres and employees of Jianfeng Cable Company to cheer up, build confidence, pay close attention to market changes, pay attention to prevent the intellectual property risks of OEM products and the sales risks brought by raw material price fluctuations, and strengthen cost control. At the same time, strengthen technical research and strive to build independent brands and markets, increase profitability and strive for greater benefits. (this newspaper reporter)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page